Galderma Laboratories, L.P.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$80.3M
Doctors Paid
34,217
Transactions
342,783
2024 Total
$16.8M
Payment Breakdown by Category
Food & Beverage$8.2M (10.2%)
Consulting$6.0M (7.4%)
Travel$4.3M (5.3%)
Research$1.5M (1.9%)
Royalty/License$292,306 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56.1M | 21,236 | 69.9% |
| Food and Beverage | $8.2M | 295,892 | 10.2% |
| Consulting Fee | $6.0M | 1,683 | 7.4% |
| Travel and Lodging | $4.3M | 20,900 | 5.3% |
| Grant | $3.8M | 146 | 4.7% |
| Unspecified | $1.5M | 343 | 1.9% |
| Royalty or License | $292,306 | 6 | 0.4% |
| Education | $68,774 | 2,297 | 0.1% |
| Honoraria | $60,758 | 280 | 0.1% |
Payments by Type
General
$78.8M
342,440 transactions
Research
$1.5M
343 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A PROSPECTIVE, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE LONG-TERM SAFETY OF SCULPTRA AESTHETIC IN IMMUNO-COMPETENT SUBJECTS STRATIFIED BY FITZPATRICK SKIN TYPE I-VI | $545,355 | 4 | 37 |
| EFFICACY AND SAFETY OF ADAPALENE 0.35BENZOYL PEROXIDE 2.5 GEL PLUS DOXYCYCLINE IN SEVERE INFLAMMATORY ACNE NON-NODULOCYSTIC SUBJECTS | $405,963 | 7 | 86 |
| 43BBJ1911 | $277,942 | 13 | 77 |
| A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis | $147,295 | 7 | 61 |
| A Double-Blind, Placebo-Controlled, Randomized Study to Assess the Durability of Effect and Safety of Nemolizumab for 24 Weeks in Subjects With Prurigo Nodularis | $85,983 | 4 | 68 |
| A MULTI-CENTER COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF TWO ACNE REGIMENS IN SUBJECTS WITH MILD TO MODERATE ACNE | $52,670 | 0 | 5 |
| A Multicenter, Open-Label, Single-Group Clinical Trial to Assess the Pharmacokinetics, Safety and Efficacy of Nemolizumab (CD14152) in Pediatric Subjects (aged 2 to 11 years) with Moderate-to-Severe Atopic Dermatitis | $11,994 | 5 | 6 |
| 43USRV1906 | $1,800 | 1 | 1 |
| A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Nemolizumab in Subjects with Chronic Kidney Disease with Associated Moderate to Severe Pruritus | $900.00 | 2 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Sabrina Fabi, M.d, M.D | Dermatology | San Diego, CA | $900,097 | $0 |
| Dr. Steven Weiner, M.d, M.D | Specialist | Santa Rosa Beach, FL | $742,323 | $0 |
| Christopher Surek, D.o, D.O | Student in an Organized Health Care Education/Training Program | Cleveland, OH | $699,511 | $0 |
| Shino Aguilera, Do, DO | Dermatology | Ft Lauderdale, FL | $680,743 | $0 |
| Richard Swift, Md, MD | Plastic Surgery | New York, NY | $673,368 | $0 |
| Michael Somenek, M.d, M.D | Otolaryngology | Washington, DC | $671,348 | $0 |
| Dr. Gideon Kwok, Do, DO | Legal Medicine | Rancho Cucamonga, CA | $661,987 | $0 |
| Nina Deep, M.d, M.D | Internal Medicine | Westerville, OH | $648,212 | $0 |
| Dr. Keith Marcus, Md, MD | Student in an Organized Health Care Education/Training Program | Ann Arbor, MI | $622,223 | $0 |
| Dr. Burke Robinson, M.d, M.D | Specialist | Alpharetta, GA | $621,522 | $0 |
| Dr. Jason Bloom, Md, MD | Otolaryngology | Bryn Mawr, PA | $599,079 | $0 |
| Daryoush Saadat, Md, MD | Facial Plastic Surgery | Valencia, CA | $591,243 | $0 |
| Ms. Lauren Meade, Pa-C, PA-C | Physician Assistant | Lexington, KY | $586,027 | $0 |
| Dr. George Baxter-Holder, Arnp, ARNP | Adult Health | Seattle, WA | $580,375 | $0 |
| Dr. Hilary Baldwin, M.d, M.D | Dermatology | Brooklyn, NY | $577,611 | $0 |
| Yula Indeyeva, M.d, M.D | Otolaryngology/Facial Plastic Surgery | Austin, TX | $552,562 | $0 |
| Dr. Neil Sadick, M.d, M.D | Dermatology | New York, NY | $535,327 | $0 |
| Julie Harper, Md, MD | Dermatology | Birmingham, AL | $526,967 | $0 |
| Dr. Anil Rajani, Md, MD | Family Medicine | Hood River, OR | $498,916 | $0 |
| Steven Dayan, M.d, M.D | Plastic Surgery | Chicago, IL | $497,989 | $0 |
| Ms. Selina Santos, Pa-C, PA-C | Physician Assistant | Austin, TX | $452,115 | $0 |
| Kian Karimi, Md, MD | Facial Plastic Surgery | Los Angeles, CA | $445,863 | $0 |
| Linda Stein Gold, M.d, M.D | Dermatology | West Bloomfield, MI | $439,990 | $0 |
| Kelly Choi, Msn, Fnp-C, MSN, FNP-C | Registered Nurse | Rancho Cucamonga, CA | $422,442 | $0 |
| Julie Woodward, Md, MD | Ophthalmology | Durham, NC | $419,244 | $0 |
Ad
Top Products
- AKLIEF $6.4M
- EPIDUO FORTE $3.5M
Associated Products (9)
Payment Categories
- Food & Beverage $8.2M
- Consulting $6.0M
- Travel & Lodging $4.3M
- Research $1.5M
- Royalties $292,306
About Galderma Laboratories, L.P.
Galderma Laboratories, L.P. has made $80.3M in payments to 34,217 healthcare providers, recorded across 342,783 transactions in the CMS Open Payments database. In 2024, the company paid $16.8M. The top product by payment volume is AKLIEF ($6.4M).
Payments were distributed across 247 medical specialties. The top specialty by payment amount is Dermatology ($26.4M to 7,459 doctors).
Payment categories include: Food & Beverage ($8.2M), Consulting ($6.0M), Research ($1.5M), Travel & Lodging ($4.3M), Royalties ($292,306).
Galderma Laboratories, L.P. is associated with 9 products in the CMS Open Payments database, including AKLIEF, EPIDUO FORTE, and ORACEA.